Beamion BCGC-1: phase Ib/II trial of zongertinib for advanced HER2-positive breast or gastroesophageal cancers
Beamion BCGC-1:zongertinib治疗晚期HER2阳性乳腺癌或胃食管癌的Ib/II期试验
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2569553
Hurvitz, Sara; Simonelli, Matteo; Yarza, Ramón; Berz, David; Kitano, Shigehisa; Del Conte, Gianluca; Acosta Eyzaguirre, Daniel; Doger de Speville Uribe, Bernard Gaston; Maier, Daniela; Erzen, Damijan; Aykut Yazgili, Sila; Curigliano, Giuseppe; Deng, Ting; Yan, Min; Zhang, Qingyuan; Wang, Xian; Nakayama, Izuma; Shitara, Kohei